KR930700097A - 수성 현탁액제의 제조방법 - Google Patents

수성 현탁액제의 제조방법

Info

Publication number
KR930700097A
KR930700097A KR1019920702981A KR920702981A KR930700097A KR 930700097 A KR930700097 A KR 930700097A KR 1019920702981 A KR1019920702981 A KR 1019920702981A KR 920702981 A KR920702981 A KR 920702981A KR 930700097 A KR930700097 A KR 930700097A
Authority
KR
South Korea
Prior art keywords
high molecular
hydroxypropylmethylcellulose
pentyloxyphenyl
ethoxy
soluble high
Prior art date
Application number
KR1019920702981A
Other languages
English (en)
Other versions
KR0181973B1 (ko
Inventor
히사유키 나카야마
카즈미치 우시오
카츠히로 이나다
Original Assignee
오가타 가즈미
센주 세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오가타 가즈미, 센주 세이야쿠 가부시키가이샤 filed Critical 오가타 가즈미
Publication of KR930700097A publication Critical patent/KR930700097A/ko
Application granted granted Critical
Publication of KR0181973B1 publication Critical patent/KR0181973B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Lasers (AREA)
  • Lighting Device Outwards From Vehicle And Optical Signal (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

내용 없음.

Description

수성 현탁액제의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. 폴리비닐 알콜, 폴리비닐피롤리돈, 히드록시프로필메틸셀룰로스, 메틸셀룰로스 및 히드록시에틸셀룰로스로 구성된 수용성 고분자 화합물 군에서 선택된 하나이상의 것 및 5-(3-에톡시-4-n-펜틸옥시페닐)티아졸리딘-2,4-디온을 용해시킨 pH8이상인 수용액에 산을 첨가하여 pH를 7이하로 조정하는 것을 특징으로 하는 미세한 5-(3-에톡시-4-n-펜틸옥시페닐)티아졸리딘-2,4-디온의 수성 현탁액제의 제조방법.
  2. 제1항에 있어서, 상기 수용액내의 수용성 고분자 화합물 및 5-(3-에톡시-4-n-펜틸옥시페닐)티아졸리딘-2,4-디온의 농도가 각각 0.1 내지 10w/w% 및 0.5wt/wt이상인 방법.
  3. 제1항에 있어서, 상기 선택된 수용성 고분자 화합물이 히드록시프로필메틸셀룰로스인 방법.
  4. 제1항에 있어서, 상기 선택된 수용성 고분자 화합물이 히드록시프로필메틸셀룰로스 및 폴리비닐롤리돈인 방법.
  5. 제1항에 있어서, 상기 선택된 수용성 고분자 화합물이 히드록시프로필메틸셀룰로스 및 폴리비닐 알콜인 방법.
  6. 제1항에 있어서, 상기 선택된 수용성 고분자 화합물이 히드록시프로필메틸셀룰로스 및 히드록시에틸셀룰 로스인 방법.
  7. 제1항에 있어서, 상기 수용액의 pH가 10 내지 13인 방법.
  8. 제1항에 있어서, 상기 산을 적가하여 용액의 pH를 4 내지 6으로 조정하는 방법.
  9. 입자직경이 10㎛이하인 미세한 5-(3-에톡시-4-n-펜틸옥시페닐)티아졸리딘-2,4디온을 현탁시킨 국소투여용 수성 점안제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920702981A 1991-03-27 1991-07-11 수성 현탁액제의 제조 방법 KR0181973B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP91-62909 1991-03-27
JP6290991 1991-03-27
JP91-062909 1991-03-27
PCT/JP1991/000932 WO1992017174A1 (en) 1991-03-27 1991-07-11 Process for preparing aqueous suspension

Publications (2)

Publication Number Publication Date
KR930700097A true KR930700097A (ko) 1993-03-13
KR0181973B1 KR0181973B1 (ko) 1999-05-01

Family

ID=13213855

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920702981A KR0181973B1 (ko) 1991-03-27 1991-07-11 수성 현탁액제의 제조 방법

Country Status (14)

Country Link
US (1) US5366985A (ko)
EP (1) EP0531529B1 (ko)
KR (1) KR0181973B1 (ko)
AT (1) ATE145328T1 (ko)
AU (2) AU650889B2 (ko)
CA (1) CA2083842A1 (ko)
DE (1) DE69123248T2 (ko)
DK (1) DK0531529T3 (ko)
ES (1) ES2094227T3 (ko)
FI (1) FI100694B (ko)
NO (1) NO301215B1 (ko)
RU (1) RU2098094C1 (ko)
TW (1) TW207500B (ko)
WO (1) WO1992017174A1 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101491965B1 (ko) * 2006-10-26 2015-02-10 오츠카 세이야쿠 가부시키가이샤 레바미피드 함유 수성 현탁액제 및 그의 제조 방법

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1284030B1 (it) * 1996-06-18 1998-05-08 Solchem Italiana Spa Metodo per la produzione di sospensioni acquose stabili, utili nelle composizioni farmaceutiche
WO1998051281A1 (fr) 1997-05-14 1998-11-19 Senju Pharmaceutical Co., Ltd. Preparations a base de suspensions aqueuses possedant d'excellentes proprietes de redispersion
EP1172097B1 (en) * 1999-04-12 2004-09-08 Shionogi & Co., Ltd. Process for producing medicinal composition of a basic hydrophobic medicinal compound
US7947295B2 (en) 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
CA2839898C (en) * 2003-06-13 2017-01-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
TWI363626B (en) 2004-11-15 2012-05-11 Otsuka Pharma Co Ltd Aqueous ophthalmic suspension of crystalline rebamipide
US20070110812A1 (en) * 2005-11-14 2007-05-17 Bausch & Lomb Incorporated Ophthalmic composition for dry eye therapy
TW200808375A (en) * 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6610081A (en) * 1980-01-24 1981-07-30 Senju Pharmaceutical Co., Ltd. Thiazolidine derivatives
JPS6143114A (ja) * 1984-08-03 1986-03-01 Takeda Chem Ind Ltd 虹彩・毛様体疾患治療用眼局所投与剤
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101491965B1 (ko) * 2006-10-26 2015-02-10 오츠카 세이야쿠 가부시키가이샤 레바미피드 함유 수성 현탁액제 및 그의 제조 방법

Also Published As

Publication number Publication date
AU6188894A (en) 1994-06-30
AU650889B2 (en) 1994-07-07
NO301215B1 (no) 1997-09-29
DK0531529T3 (da) 1997-04-21
FI100694B (fi) 1998-02-13
AU8104791A (en) 1992-11-02
KR0181973B1 (ko) 1999-05-01
EP0531529A1 (en) 1993-03-17
ES2094227T3 (es) 1997-01-16
EP0531529A4 (en) 1993-08-04
NO924549D0 (no) 1992-11-25
ATE145328T1 (de) 1996-12-15
DE69123248D1 (de) 1997-01-02
FI925353A (fi) 1992-11-25
US5366985A (en) 1994-11-22
FI925353A0 (fi) 1992-11-25
EP0531529B1 (en) 1996-11-20
RU2098094C1 (ru) 1997-12-10
WO1992017174A1 (en) 1992-10-15
TW207500B (ko) 1993-06-11
AU661944B2 (en) 1995-08-10
NO924549L (no) 1992-11-25
CA2083842A1 (en) 1992-09-28
DE69123248T2 (de) 1997-03-13

Similar Documents

Publication Publication Date Title
ES2173204T3 (es) Formacion de particulas pequeñas.
BR9507640A (pt) Processo para estabilizar derivados de duocarmicida e composição farmacêutica
NO940111D0 (no) Farmasoeytiske preparater inneholdene nanokapsler
DE69521686D1 (de) Ophtalmische zubereitung niedriger viskosität
KR930700097A (ko) 수성 현탁액제의 제조방법
KR920003971A (ko) 점안액 조성물
KR940021071A (ko) 생체기능조정물질
US4665089A (en) Process for preventing or reversing cataract formation using protein modification reagents
KR900015612A (ko) 글루타르알데하이드와 1,2-벤즈이소티아졸린-3-온의 수성 농축 용액
FI940224A0 (fi) Oksikamia tai oksikamijohdannaisia sisältävät oftalmiset koostumukset
DK0625903T3 (da) Topiske antiglaukompræparater omfattende carbonsyreanhydraseinhibitorer og beta-blokkere
KR890008136A (ko) 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체
RU92016488A (ru) Способ получения водной суспензии
EP0365139A3 (en) Bile acids for the treatment of viral infections
EP0641563A4 (en) CATARACT REMEDY AND PROCESS FOR PRODUCING THE SAME.
CA2105793A1 (en) Process for producing compositions for ruminants
KR950010896A (ko) 근시의 예방 및 치료용 조성물
KR880007528A (ko) [3s(z)]-2[[[1-(2-아미노-4-티아졸릴)-2-[[2,2-디메틸-4-옥소-1-(술포옥시)-3-아제티디닐]아미노]-2-옥소에틸리덴]아미노]옥시]아세트산의 결정질 염류
KR890017259A (ko) 모액으로부터의 항생물질 회수방법 및 그의 약학적으로 허용할 수 있는 신규한 염
KR890009936A (ko) 그리세올산 모노에스테르류, 이의 제조방법 및 용도
KR890003725A (ko) 아민유도체 및 이의 염, 이의 제조방법 및 이를 함유하는 궤양치료제
KR900016228A (ko) 티아제토퀴놀린-3-카르복실산 유도체, 그것의 제조방법 및 그것을 유효성분으로 하는 의약
DE69008431D1 (de) Verfahren zur Herstellung von Imidazol-Derivaten.
KR840009032A (ko) 동물류 주사용 옥시테트라사이클린 수용액류와 그 제조방법
AU2001242398A1 (en) Contact lens treating method and composition

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20011205

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee